Quinazolines As Anti-cancer Agents

Quinazolines As Anti-cancer Agents


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,165

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Quinazoline derivatives have received a great interest as anti-cancer agents since the discovery of Gefitinib. From about 1995 to 2006, the anticancer quinazoline panorama has been dominated by the 4-anilinoquinazolines as tyrosine kinase inhibitors. Interests in quinazolines as anticancer agents have been further increased after the discovery of thymidylate synthase inhibitors Raltitrexed and Thymitaq. The aim of this book is to provide a brief overview of synthesis and pharmacology of quinazoline based anti-cancer agents. The first chapter provides a brief review of conventional and targeted anti-cancer agents and also elaborates on the special place held by quinazoline derivatives in the current anti-cancer chemotherapy. The second chapter is aimed at providing a review of reported synthetic strategies and pharmacological properties of clinically approved quinazoline kinase inhibitors. The third chapter covers the reported synthetic strategies and information on pharmacology of various quinazoline kinase inhibitors which are currently under clinical trials. The fourth chapter covers the literature on anti-cancer activity of quinazoline derivatives reported in the past decade.

Product Specifications
SKU :COC55619
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-06-08
0 Review(s)